Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 4Thoracic 2Other hematologic neoplasm 2Myeloid 2Gynecologic 2CNS 2Tumor-Agnostic 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
DNA × Thoracic × Clear all
NCT04215913 2020-01-02

PSC

Shanghai 10th People's Hospital

Unknown
300 enrolled
Thoracic

Lung Neoplasms

NCT00793208 2019-04-12

Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)

University of Pittsburgh

Phase 1 Terminated
1 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡